Laura Modiano

Laura Modiano

About

Detail

Founder Experience
London, England, United Kingdom

Timeline

work
Job
school
Education
flag
Award
auto_stories
Publication

Résumé

Jobs verified_user 0% verified
  • OpenAI
    Founder Experience
    OpenAI
    May 2026 - Current (2 months)
  • OpenAI
    Startups EMEA
    OpenAI
    Sep 2024 - Current (1 year 10 months)
  • OpenAI
    Startups
    OpenAI
    Sep 2024 - May 2026 (1 year 9 months)
  • Amazon Web Services AWS
    Principal VC and Startups BD, EMEA
    Amazon Web Services AWS
    Sep 2022 - Aug 2024 (2 years)
  • Angel Investor
    Angel Investor
    Angel Investor
    Mar 2021 - Current (5 years 4 months)
  • Amazon Web Services AWS
    HCLS Startups BD, EMEA
    Amazon Web Services AWS
    Sep 2020 - Aug 2022 (2 years)
  • S
    Startup, technology and AI innovation advisor
    Startups and hospitals
    Jul 2018 - Sep 2020 (2 years 3 months)
  • NHS England
    Head of strategy for Genetic Testing in England
    NHS England
    Jun 2017 - Aug 2018 (1 year 3 months)
  • University College London Hospitals NHS Foundation Trust
    Programme Lead for UCLHfuture
    University College London Hospitals NHS Foundation Trust
    Jun 2016 - Jun 2017 (1 year 1 month)
    1-year fixed term contract
  • Boston Scientific
    Healthcare Partnerships
    Boston Scientific
    Sep 2014 - Jun 2016 (1 year 10 months)
  • Monitor Group
    Senior Consultant
    Monitor Group
    Aug 2010 - Sep 2014 (4 years 2 months)
  • Amwell
    Marketing and Business Development Associate
    Amwell
    Oct 2008 - Aug 2010 (1 year 11 months)
Education verified_user 0% verified
  • University of Cambridge
    Genomic Medicine, Genomic Medicine
    University of Cambridge
    Jan 2019 - Dec 2019 (1 year)
    - Pharmacogenomics and Stratified Healthcare - Epigenetics in Human Health and Diseases
  • Imperial College London
    Genomic Medicine, Genomic Medicine
    Imperial College London
    Jan 2019 - Dec 2019 (1 year)
    - Molecular Pathology of Cancer and Application in Diagnosis, Screening and Treatment - Genome-Based Therapeutics
  • Saïd Business School University of Oxford
    Oxford Chicago Valuation Programme
    Saïd Business School University of Oxford
    Jan 2017 - Dec 2017 (1 year)
  • University of Oxford Said Business School
    Oxford Chicago Valuation Programme
    University of Oxford Said Business School
    Jan 2017 - Dec 2017 (1 year)
  • City University London
    Master of Science (MSc, Health Management
    City University London
    Jan 2016 - Dec 2016 (1 year)
  • City St Georges University of London
    Master of Science (MSc, Health Management
    City St Georges University of London
    Jan 2016 - Dec 2016 (1 year)
  • Tufts University
    BA, Psychology and Economics
    Tufts University
    Jan 2004 - Dec 2008 (5 years)
    Focused in social psychology, with a special interest in organisational psychology and negotiation
  • Imperial College London
    Molecular Pathology of Cancer and Application in Diagnosis, Screening and Treatment
    Imperial College London
Awards verified_user 0% verified
  • P
    Winning Spirit Award
    President CEO Mike Mahoney
    Jan 2015
    Award recognizing employees who help shape a culture of growth and innovation by adapting to change and acting with speed, agility and accountability to improve patient care.
Publications verified_user 0% verified
  • P
    Developing a Test Directory for Rare and Inherited Disease Genomic Testing in the National Health Service in England
    Presented in European Society of Human Genetics
    Jun 2018
  • P
    Developing frameworks to evaluate diagnostic genomic testing strategies for rare disease and cancer
    Poter presented in the American Society of Human Genetics
    Oct 2017
    Authors: R.H. Scott1; L. Modiano2; Z.C. Deans2; E.R.A Thomas1; A. Hamblin1, 3; E.V. Davison2; E. Graham2; R. Snow-Miller2; S. Wordsworth4; C. Turnbull1; N. Murugaesu1; S. Henderson 1,2; T.A. Fowler1; M.J Caulfield1; S.L. Hill2 1. NHS England, London, UK; 2. Genomics England, London, UK; 3. Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom; 4. University of Oxford, Oxford, United Kingdom
  • G
    Winners and losers in the new commodity price regime, By Peter Schwartz, Michael Costigan, Nils Gilman, Laura Modiano, N
    Global Business Network Monitor Company Group
    Jan 2011
This is a community-created genome.